Turku Bioscience Centre

Contact Details

Persons

  

  

  

1 of 10

  

  

  

---

• Aakula, Anna
• Abdelkader, Hend
• Abe, Oluwatosin
• Adel, Ketlin
• Akram, Sadia
• Alamaunu, Anneli
• Alanko, Jonna
• Andrabi, Syed
• Arsiola, Tiina
• Atefi, Atefeh
• Balint, Balazs
• Batkulwar, Kedar
• Bhardiya, Shruti Nitin
• Biradar, Rahul
• Bojovic, Itana
• Booth, Nicholas
• Buchacher, Tanja
• Chastney, Megan
• Coffey, Eleanor
• Courtney, Michael

Publications

  

  

  

12 of 175

  

  

  

---

• Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells  (2019)
• An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations  (2022)
• An unbiased in vitro screen for activating epidermal growth factor receptor mutations  (2019)
• A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-2a as first line treatment in metastatic melanoma  (2010)
• A pH-Responsive Cluster Metal-Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect  (2022)
• A pH/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy  (2023)
• A Plasmid-Based Fluorescence Reporter System for Monitoring Oxidative Damage in E. coli  (2022)
• Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines  (2022)
• Application of ADA1 as a new marker enzyme in sandwich ELISA to study the effect of adenosine on activated monocytes  (2016)
• Application of ZnO/CNT@Fe3O4 nanocomposite in amplifying the anti-leukemic effect of imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia  (2021)